| Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer M Moutafi, CJ Robbins, V Yaghoobi, AI Fernandez, S Martinez-Morilla, ... Laboratory Investigation 102 (10), 1101-1108, 2022 | 60 | 2022 |
| A new tool for technical standardization of the Ki67 immunohistochemical assay TN Aung, B Acs, J Warrell, Y Bai, P Gaule, S Martinez-Morilla, I Vathiotis, ... Modern Pathology 34 (7), 1261-1270, 2021 | 31 | 2021 |
| Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer MK Moutafi, W Tao, R Huang, J Haberberger, B Alexander, S Ramkissoon, ... Journal for immunotherapy of cancer 9 (4), 2021 | 29 | 2021 |
| The genomic profile of pregnancy-associated breast cancer: a systematic review AM Korakiti, M Moutafi, E Zografos, MA Dimopoulos, F Zagouri Frontiers in Oncology 10, 1773, 2020 | 27 | 2020 |
| PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data M Moutafi, P Economopoulou, D Rimm, A Psyrri Oral Oncology 117, 105292, 2021 | 25 | 2021 |
| Histone deacetylase (HDAC) inhibitors: A promising weapon to tackle therapy resistance in melanoma K Palamaris, M Moutafi, H Gakiopoulou, S Theocharis International Journal of Molecular Sciences 23 (7), 3660, 2022 | 21 | 2022 |
| Discovery of biomarkers of resistance to immune checkpoint blockade in NSCLC using high-plex digital spatial profiling M Moutafi, S Martinez-Morilla, P Divakar, I Vathiotis, N Gavrielatou, ... Journal of Thoracic Oncology 17 (8), 991-1001, 2022 | 18 | 2022 |
| Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer MK Moutafi, M Molero, SM Morilla, J Baena, IA Vathiotis, N Gavrielatou, ... Journal for immunotherapy of cancer 10 (8), 2022 | 18 | 2022 |
| Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms TN Aung, S Shafi, JS Wilmott, S Nourmohammadi, I Vathiotis, ... EBioMedicine 82, 2022 | 15 | 2022 |
| Multiplex immunohistochemistry and immunofluorescence: a practical update for pathologists PW Harms, TL Frankel, M Moutafi, A Rao, DL Rimm, JM Taube, D Thomas, ... Modern Pathology 36 (7), 100197, 2023 | 14 | 2023 |
| A new genetic variant of hereditary apolipoprotein AI amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options M Moutafi, DC Ziogas, S Michopoulos, T Bagratuni, V Vasileiou, L Verga, ... BMC medical genetics 20, 1-5, 2019 | 14 | 2019 |
| Alpha-smooth muscle actin expression in the stroma predicts resistance to trastuzumab in patients with early-stage HER2-positive breast cancer IA Vathiotis, MK Moutafi, P Divakar, TN Aung, T Qing, A Fernandez, ... Clinical Cancer Research 27 (22), 6156-6163, 2021 | 13 | 2021 |
| Digital spatial profiling links beta-2-microglobulin expression with immune checkpoint blockade outcomes in head and neck squamous cell carcinoma N Gavrielatou, I Vathiotis, TN Aung, S Shafi, S Burela, AI Fernandez, ... Cancer Research Communications 3 (4), 558-563, 2023 | 7 | 2023 |
| Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance DA Schoenfeld, RD Merkin, M Moutafi, S Martinez, A Adeniran, D Kumar, ... Frontiers in Oncology 12, 990367, 2022 | 7 | 2022 |
| Programmed death-ligand 1 and programmed death-ligand 2 mRNAs measured using closed-system quantitative real-time polymerase chain reaction are associated with outcome and high … AI Fernandez, N Gavrielatou, L McCann, S Shafi, MK Moutafi, ... Journal of Thoracic Oncology 17 (9), 1078-1085, 2022 | 7 | 2022 |
| Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC) P Economopoulou, A Spathis, I Kotsantis, E Maratou, M Anastasiou, ... Oral Oncology 139, 106358, 2023 | 6 | 2023 |
| Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer S Shafi, TN Aung, V Xirou, N Gavrielatou, IA Vathiotis, A Fernandez, ... Laboratory Investigation 102 (10), 1143-1149, 2022 | 6 | 2022 |
| Standardization of PD-L1 immunohistochemistry S Martinez-Morilla, M Moutafi, DL Rimm Modern Pathology 35 (3), 294-295, 2022 | 6 | 2022 |
| Young oncologists’ perspective on the role and future of the clinician-scientist in oncology KHJ Lim, CB Westphalen, AS Berghoff, C Cardone, EA Connolly, ... ESMO open 8 (5), 2023 | 5 | 2023 |
| Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study V Yaghoobi, M Moutafi, TN Aung, V Pelekanou, S Yaghoubi, K Blenman, ... Breast Cancer Research 23, 1-12, 2021 | 5 | 2021 |
